Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 121.5 | 52 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 183.0 | 45 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | IL-1RA | 190.0 | 47 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 132.0 | 82 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-1RA | 153.0 | 62 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 180.0 | 58 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-1RA | 196.0 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 145.0 | 57 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-1RA | 147.0 | 51 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 25.0 | 56 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 32.0 | 37 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 26.0 | 55 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 30.0 | 45 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 23.0 | 57 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 34.5 | 42 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 28.0 | 47 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 31.0 | 59 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 84.5 | 62 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 95.0 | 43 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 78.5 | 64 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 93.5 | 44 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 83.0 | 59 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 87.5 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 103.0 | 51 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 97.0 | 51 |